English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Dec 25, 2025

FDA approves expanded use of Amgen's Uplizna for generalized myasthenia gravis

Patient Daily | Dec 25, 2025

Nanjing Agricultural University team engineers sustainable system for scalable cultured pork

Patient Daily | Dec 25, 2025

Study finds increased heart attack risk linked to vaping in former smokers

Patient Daily | Dec 25, 2025

Metabolic syndrome affects four in ten US adults; disparities widen for seniors and Black Americans

Patient Daily | Dec 25, 2025

FDA approves GSK’s Blujepa as first new gonorrhea antibiotic class in over three decades

Patient Daily | Dec 25, 2025

CDC study finds COVID-19 vaccines reduce emergency visits for young children

Patient Daily | Dec 25, 2025

Longevitix seeks to help scale longevity medicine by addressing operational barriers

Patient Daily | Dec 25, 2025

Five dangerous parasites increasingly threaten public health amid climate change

Trending

+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'

+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal

+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'

+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug

  • « First
  • «
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily